Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Institute Of Chinese Materia Medica China Academy Of Chinese Medical Sciences has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed across 4 examiners and 4 art units, giving each matter a distinct examination setting.
SPANGLER, JOSEPH RANKIN is the busiest examiner, with 1 pending matter. Prosecution management should emphasize matter-level preparation and avoid assuming that an approach developed for one assignment will transfer across the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPANGLER, JOSEPH RANKIN | 1 | 40.8% | +70.6% |
| SUN, XIUQIN | 1 | 72.5% | +4.2% |
| OH, TAYLOR V | 1 | 81.3% | +15.3% |
| OLSON, ANDREA STEFFEL | 1 | 62.4% | -11.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19048825 | FLAVONOID GLYCOSIDE GLYCOSYLTRANSFERASE LbUGT71BX1 IN LAPORTEA BULBIFERA AS WELL AS THE CODING GENE AND THE USE THEREOF | SPANGLER, JOSEPH RANKIN | — |
| 19026531 | METHOD FOR QUANTIFYING MULTIPLY COMPOUNDS WITH SAME CHROMOPHORE USING SINGLE STANDARD | SUN, XIUQIN | — |
| 18833602 | CYCLIC(ALKYL)(AMINO)ALKOXY-SUBSTITUTED ARYL-PYRONE COMPOUND AND USE THEREOF | OH, TAYLOR V | — |
| 18646814 | APPLICATION OF TYPHANEOSIDE IN PREPARATION OF MEDICINE FOR URIC ACID-LOWERING AND/OR KIDNEY INJURY | OLSON, ANDREA STEFFEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19048825 | FLAVONOID GLYCOSIDE GLYCOSYLTRANSFERASE LbUGT71BX1 IN LAPORTEA BULBIFERA AS WELL AS THE CODING GENE AND THE USE THEREOF | SPANGLER, JOSEPH RANKIN | — |
| 18833602 | CYCLIC(ALKYL)(AMINO)ALKOXY-SUBSTITUTED ARYL-PYRONE COMPOUND AND USE THEREOF | OH, TAYLOR V | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| 2857 | 1 |
| 1625 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19048825 | FLAVONOID GLYCOSIDE GLYCOSYLTRANSFERASE LbUGT71BX1 IN LAPORTEA BULBIFERA AS WELL AS THE CODING GENE AND THE USE THEREOF | SPANGLER, JOSEPH RANKIN | 1656 | §101§112 | Non-Final OA | — | Pending | Feb 07, 2025 |
| 19026531 | METHOD FOR QUANTIFYING MULTIPLY COMPOUNDS WITH SAME CHROMOPHORE USING SINGLE STANDARD | SUN, XIUQIN | 2857 | §101§112 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18833602 | CYCLIC(ALKYL)(AMINO)ALKOXY-SUBSTITUTED ARYL-PYRONE COMPOUND AND USE THEREOF | OH, TAYLOR V | 1625 | §101§102§112 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18646814 | APPLICATION OF TYPHANEOSIDE IN PREPARATION OF MEDICINE FOR URIC ACID-LOWERING AND/OR KIDNEY INJURY | OLSON, ANDREA STEFFEL | 1693 | §101§102§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitute Of Chinese Materia Medica China Academy Of Chinese Medical Sciences has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Joseph Rankin Spangler has the most, with 1 of Institute Of Chinese Materia Medica China Academy Of Chinese Medical Sciences's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
